| Scrip Code | 543635 |
|---|---|
| NSE Symbol | PPLPHARMA |
| MSEI Symbol | NOTLISTED |
| ISIN | INE0DK501011 |
| Name of company | PIRAMAL PHARMA LIMITED |
| Type of company | Main Board |
| Class of security | Equity |
| Date of start of financial year | 01-04-2025 |
| Date of end of financial year | 31-03-2026 |
| Date of board meeting when results were approved | 05-11-2025 |
| Date on which prior intimation of the meeting for considering financial results was informed to the exchange | 24-10-2025 |
| Description of presentation currency | INR |
| Level of rounding used in financial results | Lakhs |
| Reporting Type | Quarterly |
| Reporting Quarter | Second quarter |
| Nature of report standalone or consolidated | Consolidated |
| Whether results are audited or unaudited for the quarter ended | Unaudited |
| Whether results are audited or unaudited for the Year to date for current period ended/year ended | Unaudited |
| Segment Reporting | Single segment |
| Description of single segment | Pharmaceuticals |
| Start date and time of board meeting | 05-11-2025 17:30:00 |
| End date and time of board meeting | 05-11-2025 20:40:00 |
| Whether cash flow statement is applicable on company | Yes |
| Type of cash flow statement | Cash Flow Indirect |
| Declaration of unmodified opinion or statement on impact of audit qualification | Not applicable |
| Particulars | 3 months/ 6 months ended (dd-mm-yyyy) | Year to date figures for current period ended (dd-mm-yyyy) | |
|---|---|---|---|
| A | Date of start of reporting period | 01-07-2025 | 01-04-2025 |
| B | Date of end of reporting period | 30-09-2025 | 30-09-2025 |
| C | Whether results are audited or unaudited | Unaudited | Unaudited |
| D | Nature of report standalone or consolidated | Consolidated | Consolidated |
| 1 | Income | ||
| Revenue from operations | 2,04,372.00 | 3,97,744.00 | |
| Other income | 6,560.00 | 12,400.00 | |
| Total income | 2,10,932.00 | 4,10,144.00 | |
| 2 | Expenses | ||
| (a) | Cost of materials consumed | 48,342.00 | 1,00,777.00 |
| (b) | Purchases of stock-in-trade | 37,483.00 | 71,766.00 |
| (c) | Changes in inventories of finished goods, work-in-progress and stock-in-trade | (15,575.00) | (32,888.00) |
| (d) | Employee benefit expense | 61,146.00 | 1,23,005.00 |
| (e) | Finance costs | 8,242.00 | 16,857.00 |
| (f) | Depreciation, depletion and amortisation expense | 20,284.00 | 40,012.00 |
| (f) | Other Expenses | ||
| 1 | Other Expenses (Net) | 57,107.00 | 1,08,545.00 |
| Total other expenses | 57,107.00 | 1,08,545.00 | |
| Total expenses | 2,17,029.00 | 4,28,074.00 | |
| 3 | Total profit before exceptional items and tax | (6,097.00) | (17,930.00) |
| 4 | Exceptional items | 0.00 | 2,074.00 |
| 5 | Total profit before tax | (6,097.00) | (15,856.00) |
| 6 | Tax expense | ||
| 7 | Current tax | 5,534.00 | 8,956.00 |
| 8 | Deferred tax | (230.00) | (3,384.00) |
| 9 | Total tax expenses | 5,304.00 | 5,572.00 |
| 10 | Net movement in regulatory deferral account balances related to profit or loss and the related deferred tax movement | 0.00 | 0.00 |
| 11 | Net Profit Loss for the period from continuing operations | (11,401.00) | (21,428.00) |
| 12 | Profit (loss) from discontinued operations before tax | 0.00 | 0.00 |
| 13 | Tax expense of discontinued operations | 0.00 | 0.00 |
| 14 | Net profit (loss) from discontinued operation after tax | 0.00 | 0.00 |
| 15 | Share of profit (loss) of associates and joint ventures accounted for using equity method | 1,479.00 | 3,336.00 |
| 16 | Total profit (loss) for period | (9,922.00) | (18,092.00) |
| 17 | Other comprehensive income net of taxes | 7,091.00 | 11,504.00 |
| 18 | Total Comprehensive Income for the period | (2,831.00) | (6,588.00) |
| 19 | Total profit or loss, attributable to | ||
| Profit or loss, attributable to owners of parent | (9,922.00) | (18,092.00) | |
| Total profit or loss, attributable to non-controlling interests | |||
| 20 | Total Comprehensive income for the period attributable to | ||
| Comprehensive income for the period attributable to owners of parent | (2,831.00) | (6,588.00) | |
| Total comprehensive income for the period attributable to owners of parent non-controlling interests | |||
| 21 | Details of equity share capital | ||
| Paid-up equity share capital | 1,32,552.00 | 1,32,552.00 | |
| Face value of equity share capital | 10 | 10 | |
| 27 | Details of debt securities | ||
| 22 | Reserves excluding revaluation reserve | ||
| 23 | Earnings per share | ||
| i | Earnings per equity share for continuing operations | ||
| Basic earnings (loss) per share from continuing operations | -0.75 | -1.37 | |
| Diluted earnings (loss) per share from continuing operations | -0.75 | -1.37 | |
| ii | Earnings per equity share for discontinued operations | ||
| Basic earnings (loss) per share from discontinued operations | 0 | 0 | |
| Diluted earnings (loss) per share from discontinued operations | 0 | 0 | |
| ii | Earnings per equity share | ||
| Basic earnings (loss) per share from continuing and discontinued operations | -0.75 | -1.37 | |
| Diluted earnings (loss) per share from continuing and discontinued operations | -0.75 | -1.37 | |
| 24 | Debt equity ratio | ||
| 25 | Debt service coverage ratio | ||
| 26 | Interest service coverage ratio | ||
| 27 | Disclosure of notes on financial results | Textual Information(1) | |
| Textual Information(1) | Refer to the consolidated financial results submitted on November 05, 2025, to the Stock Exchange. |
|---|
| Debt equity ratio | |
|---|---|
| Debt service coverage ratio | |
| Interest service coverage ratio |
| Particulars | Year ended (dd-mm-yyyy) | ||
|---|---|---|---|
| Date of start of reporting period | 01-04-2025 | ||
| Date of end of reporting period | 30-09-2025 | ||
| Whether results are audited or unaudited | Unaudited | ||
| Nature of report standalone or consolidated | Consolidated | ||
| Assets | |||
| 1 | Non-current assets | ||
| Property, plant and equipment | 4,30,388.00 | ||
| Capital work-in-progress | 56,675.00 | ||
| Investment property | 0.00 | ||
| Goodwill | 1,18,835.00 | ||
| Other intangible assets | 2,46,225.00 | ||
| Intangible assets under development | 52,131.00 | ||
| Biological assets other than bearer plants | 0.00 | ||
| Investments accounted for using equity method | 21,998.00 | ||
| Non-current financial assets | |||
| Non-current investments | 4,431.00 | ||
| Trade receivables, non-current | 0.00 | ||
| Loans, non-current | 0.00 | ||
| Other non-current financial assets | 2,282.00 | ||
| Total non-current financial assets | 6,713.00 | ||
| Deferred tax assets (net) | 45,269.00 | ||
| Other non-current assets | 45,407.00 | ||
| Total non-current assets | 10,23,641.00 | ||
| 2 | Current assets | ||
| Inventories | 2,74,283.00 | ||
| Current financial asset | |||
| Current investments | 22,248.00 | ||
| Trade receivables, current | 1,98,459.00 | ||
| Cash and cash equivalents | 49,944.00 | ||
| Bank balance other than cash and cash equivalents | 2,214.00 | ||
| Loans, current | 0.00 | ||
| Other current financial assets | 2,813.00 | ||
| Total current financial assets | 2,75,678.00 | ||
| Current tax assets (net) | 537.00 | ||
| Other current assets | 44,804.00 | ||
| Total current assets | 5,95,302.00 | ||
| 3 | Non-current assets classified as held for sale | 0.00 | |
| 4 | Regulatory deferral account debit balances and related deferred tax Assets | 0.00 | |
| Total assets | 16,18,943.00 | ||
| Equity and liabilities | |||
| 1 | Equity | ||
| Equity attributable to owners of parent | |||
| Equity share capital | 1,32,552.00 | ||
| Other equity | 6,74,827.00 | ||
| Total equity attributable to owners of parent | 8,07,379.00 | ||
| Non controlling interest | |||
| Total equity | 8,07,379.00 | ||
| 2 | Liabilities | ||
| Non-current liabilities | |||
| Non-current financial liabilities | |||
| Borrowings, non-current | 3,31,685.00 | ||
| Trade payables, non-current | |||
| (A) Total outstanding dues of micro enterprises and small enterprises | 0.00 | ||
| (B) Total outstanding dues of creditors other than micro enterprises and small enterprises | 0.00 | ||
| Total Trade payable | 0.00 | ||
| Other non-current financial liabilities | 9,955.00 | ||
| Total non-current financial liabilities | 3,41,640.00 | ||
| Provisions, non-current | 9,044.00 | ||
| Deferred tax liabilities (net) | 26,713.00 | ||
| Deferred government grants, Non-current | 0.00 | ||
| Other non-current liabilities | 18,193.00 | ||
| Total non-current liabilities | 3,95,590.00 | ||
| Current liabilities | |||
| Current financial liabilities | |||
| Borrowings, current | 1,39,859.00 | ||
| Trade payables, current | |||
| (A) Total outstanding dues of micro enterprises and small enterprises | 7,693.00 | ||
| (B) Total outstanding dues of creditors other than micro enterprises and small enterprises | 1,75,130.00 | ||
| Total Trade payable | 1,82,823.00 | ||
| Other current financial liabilities | 37,071.00 | ||
| Total current financial liabilities | 3,59,753.00 | ||
| Other current liabilities | 52,856.00 | ||
| Provisions, current | 1,704.00 | ||
| Current tax liabilities (Net) | 1,661.00 | ||
| Deferred government grants, Current | 0.00 | ||
| Total current liabilities | 4,15,974.00 | ||
| 3 | Liabilities directly associated with assets in disposal group classified as held for sale | 0.00 | |
| 4 | Regulatory deferral account credit balances and related deferred tax liability | 0.00 | |
| Total liabilities | 8,11,564.00 | ||
| Total equity and liabilites | 16,18,943.00 | ||
| Disclosure of notes on assets and liabilities | Textual Information(1) | ||
| Textual Information(1) | Refer to the consolidated financial results submitted on November 05, 2025, to the Stock Exchange. |
|---|
| Particulars | 3 months/ 6 month ended (dd-mm-yyyy) | Year to date figures for current period ended (dd-mm-yyyy) | |||||
|---|---|---|---|---|---|---|---|
| Date of start of reporting period | 01-07-2025 | 01-04-2025 | |||||
| Date of end of reporting period | 30-09-2025 | 30-09-2025 | |||||
| Whether results are audited or unaudited | Unaudited | Unaudited | |||||
| Nature of report standalone or consolidated | Consolidated | Consolidated | |||||
| 1 | Segment Revenue (Income) | ||||||
| (net sale/income from each segment should be disclosed) | |||||||
| Total Segment Revenue | |||||||
| Less: Inter segment revenue | |||||||
| Revenue from operations | |||||||
| 2 | Segment Result | ||||||
| Profit (+) / Loss (-) before tax and interest from each segment | |||||||
| Total Profit before tax | |||||||
| i. Finance cost | |||||||
| ii. Other Unallocable Expenditure net off Unallocable income | |||||||
| Profit before tax | |||||||
| 3 | (Segment Asset - Segment Liabilities) | ||||||
| Segment Asset | |||||||
| Total Segment Asset | |||||||
| Un-allocable Assets | null | null | |||||
| Net Segment Asset | null | null | |||||
| 4 | Segment Liabilities | ||||||
| Segment Liabilities | |||||||
| Total Segment Liabilities | |||||||
| Un-allocable Liabilities | null | null | |||||
| Net Segment Liabilities | null | null | |||||
| Disclosure of notes on segments | |||||||
| Particulars | 3 months/ 6 months ended (dd-mm-yyyy) | Year to date figures for current period ended (dd-mm-yyyy) | |
|---|---|---|---|
| A | Date of start of reporting period | 01-07-2025 | 01-04-2025 |
| B | Date of end of reporting period | 30-09-2025 | 30-09-2025 |
| C | Whether results are audited or unaudited | Unaudited | Unaudited |
| D | Nature of report standalone or consolidated | Consolidated | Consolidated |
| Other comprehensive income [Abstract] | |||
| 1 | Amount of items that will not be reclassified to profit and loss | ||
| 1 | Remeasurement of Post Employment Benefit Plans | 14.00 | (473.00) |
| Total Amount of items that will not be reclassified to profit and loss | 14.00 | (473.00) | |
| 2 | Income tax relating to items that will not be reclassified to profit or loss | 4.00 | (119.00) |
| 3 | Amount of items that will be reclassified to profit and loss | ||
| 1 | Deferred gains / (losses) on cash flow hedge | (3,679.00) | (3,555.00) |
| 2 | Exchange differences on translation of foreign operations | 11,055.00 | 17,529.00 |
| 3 | Share of other comprehensive income/ (expense) of associates accounted for using the equity method | 0.00 | 0.00 |
| Total Amount of items that will be reclassified to profit and loss | 7,376.00 | 13,974.00 | |
| 4 | Income tax relating to items that will be reclassified to profit or loss | 295.00 | 2,116.00 |
| 5 | Total Other comprehensive income | 7,091.00 | 11,504.00 |
| Particulars | Year ended (dd-mm-yyyy) | |||||
|---|---|---|---|---|---|---|
| A | Date of start of reporting period | 01-04-2025 | ||||
| B | Date of end of reporting period | 30-09-2025 | ||||
| C | Whether results are audited or unaudited | Unaudited | ||||
| D | Nature of report standalone or consolidated | Consolidated | ||||
| Statement of cash flows | ||||||
| Cash flows from used in operating activities | ||||||
| Profit before tax | (15,856.00) | |||||
| Adjustments for reconcile profit (loss) | ||||||
| Adjustments for finance costs | 16,857.00 | |||||
| Adjustments for decrease (increase) in inventories | (41,696.00) | |||||
| Adjustments for decrease (increase) in trade receivables, current | 38,413.00 | |||||
| Adjustments for decrease (increase) in trade receivables, non-current | 0.00 | |||||
| Adjustments for decrease (increase) in other current assets | 10,613.00 | |||||
| Adjustments for decrease (increase) in other non-current assets | 728.00 | |||||
| Adjustments for other financial assets, non-current | (212.00) | |||||
| Adjustments for other financial assets, current | 1,462.00 | |||||
| Adjustments for other bank balances | 0.00 | |||||
| Adjustments for increase (decrease) in trade payables, current | 32,872.00 | |||||
| Adjustments for increase (decrease) in trade payables, non-current | 0.00 | |||||
| Adjustments for increase (decrease) in other current liabilities | 25,371.00 | |||||
| Adjustments for increase (decrease) in other non-current liabilities | 1,268.00 | |||||
| Adjustments for depreciation and amortisation expense | 40,012.00 | |||||
| Adjustments for impairment loss reversal of impairment loss recognised in profit or loss | 0.00 | |||||
| Adjustments for provisions, current | 603.00 | |||||
| Adjustments for provisions, non-current | 521.00 | |||||
| Adjustments for other financial liabilities, current | (5,177.00) | |||||
| Adjustments for other financial liabilities, non-current | 0.00 | |||||
| Adjustments for unrealised foreign exchange losses gains | (2,740.00) | |||||
| Adjustments for dividend income | 0.00 | |||||
| Adjustments for interest income | 221.00 | |||||
| Adjustments for share-based payments | 2,677.00 | |||||
| Adjustments for fair value losses (gains) | (23.00) | |||||
| Adjustments for undistributed profits of associates | 0.00 | |||||
| Other adjustments for which cash effects are investing or financing cash flow | (254.00) | |||||
| Other adjustments to reconcile profit (loss) | (2,074.00) | |||||
| Other adjustments for non-cash items | (5,132.00) | |||||
| Share of profit and loss from partnership firm or association of persons or limited liability partnerships | 0.00 | |||||
| Total adjustments for reconcile profit (loss) | 1,13,868.00 | |||||
| Net cash flows from (used in) operations | 98,012.00 | |||||
| Dividends received | 0.00 | |||||
| Interest paid | 0.00 | |||||
| Interest received | 0.00 | |||||
| Income taxes paid (refund) | 9,036.00 | |||||
| Other inflows (outflows) of cash | 0.00 | |||||
| Net cash flows from (used in) operating activities | 88,976.00 | |||||
| Cash flows from used in investing activities | ||||||
| Cash flows from losing control of subsidiaries or other businesses | 0.00 | |||||
| Cash flows used in obtaining control of subsidiaries or other businesses | 0.00 | |||||
| Other cash receipts from sales of equity or debt instruments of other entities | 0.00 | |||||
| Other cash payments to acquire equity or debt instruments of other entities | 0.00 | |||||
| Other cash receipts from sales of interests in joint ventures | 0.00 | |||||
| Other cash payments to acquire interests in joint ventures | 0.00 | |||||
| Cash receipts from share of profits of partnership firm or association of persons or limited liability partnerships | 0.00 | |||||
| Cash payment for investment in partnership firm or association of persons or limited liability partnerships | 0.00 | |||||
| Proceeds from sales of property, plant and equipment | 1,176.00 | |||||
| Purchase of property, plant and equipment | 43,322.00 | |||||
| Proceeds from sales of investment property | 0.00 | |||||
| Purchase of investment property | 0.00 | |||||
| Proceeds from sales of intangible assets | 0.00 | |||||
| Purchase of intangible assets | 0.00 | |||||
| Proceeds from sales of intangible assets under development | 0.00 | |||||
| Purchase of intangible assets under development | 0.00 | |||||
| Proceeds from sales of goodwill | 0.00 | |||||
| Purchase of goodwill | 0.00 | |||||
| Proceeds from biological assets other than bearer plants | 0.00 | |||||
| Purchase of biological assets other than bearer plants | 0.00 | |||||
| Proceeds from government grants | 0.00 | |||||
| Proceeds from sales of other long-term assets | 0.00 | |||||
| Purchase of other long-term assets | 0.00 | |||||
| Cash advances and loans made to other parties | 0.00 | |||||
| Cash receipts from repayment of advances and loans made to other parties | 0.00 | |||||
| Cash payments for future contracts, forward contracts, option contracts and swap contracts | 0.00 | |||||
| Cash receipts from future contracts, forward contracts, option contracts and swap contracts | 0.00 | |||||
| Dividends received | 3,746.00 | |||||
| Interest received | 255.00 | |||||
| Income taxes paid (refund) | 0.00 | |||||
| Other inflows (outflows) of cash | (8,683.00) | |||||
| Net cash flows from (used in) investing activities | (46,828.00) | |||||
| Cash flows from used in financing activities | ||||||
| Proceeds from changes in ownership interests in subsidiaries | 0.00 | |||||
| Payments from changes in ownership interests in subsidiaries | 0.00 | |||||
| Proceeds from issuing shares | 117.00 | |||||
| Proceeds from issuing other equity instruments | 0.00 | |||||
| Payments to acquire or redeem entity's shares | 0.00 | |||||
| Payments of other equity instruments | 0.00 | |||||
| Proceeds from exercise of stock options | 0.00 | |||||
| Proceeds from issuing debentures notes bonds etc | 0.00 | |||||
| Proceeds from borrowings | 54,189.00 | |||||
| Repayments of borrowings | 70,130.00 | |||||
| Payments of lease liabilities | 2,365.00 | |||||
| Dividends paid | 1,855.00 | |||||
| Interest paid | 16,055.00 | |||||
| Income taxes paid (refund) | 0.00 | |||||
| Other inflows (outflows) of cash | 0.00 | |||||
| Net cash flows from (used in) financing activities | (36,099.00) | |||||
| Net increase (decrease) in cash and cash equivalents before effect of exchange rate changes | 6,049.00 | |||||
| Effect of exchange rate changes on cash and cash equivalents | ||||||
| Effect of exchange rate changes on cash and cash equivalents | (2,225.00) | |||||
| Net increase (decrease) in cash and cash equivalents | 3,824.00 | |||||
| Cash and cash equivalents cash flow statement at beginning of period | 18,232.00 | |||||
| Cash and cash equivalents cash flow statement at end of period | 22,056.00 | |||||